Guardant Health (NASDAQ:GH) Given New $65.00 Price Target at Mizuho
Guardant Health (NASDAQ:GH – Free Report) had its price target raised by Mizuho from $60.00 to $65.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Raymond James reiterated an […]
Guardant Health (NASDAQ:GH – Free Report) had its price target raised by Mizuho from $60.00 to $65.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Raymond James reiterated an […]
